Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NR1I3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IFITM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYBPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NUCKS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD38B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM173A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORBS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTNNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL14A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PFDN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPSM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TATDN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LRCH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on